​
​

Zynerba Pharmaceuticals Ownership | Who Owns Zynerba Pharmaceuticals?

OverviewForecastChart

Zynerba Pharmaceuticals Ownership Summary

Zynerba Pharmaceuticals is owned by 0.03% institutional investors, and 99.97% retail investors. B. riley wealth advisors is the largest institutional shareholder, holding 0% of ZYNE shares. Victory Extended Market Index is the top mutual fund, with 0.01% of its assets in Zynerba Pharmaceuticals shares.

ZYNE Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockZynerba Pharmaceuticals0.03%-99.97%
SectorHealthcare Stocks 46.98%7.90%45.12%
IndustrySpecialty & Generic Drug Manufacturers Stocks34.80%9.10%56.10%
IdeaCannabis Stocks List21.30%7.65%71.06%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
B. riley wealth advisors---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
B. riley wealth advisors---

Top Buyers

HolderShares% AssetsChange
B. riley wealth advisors---12.73K

Top Sellers

HolderShares% AssetsChange
B. riley wealth advisors---12.73K

Sold Out

HolderChange
B. riley wealth advisors-12.73K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20241-12,732---1---
Sep 30, 2023447.32%11,505,090115.69%2220.28%2283.33%10-16.67%
Jun 30, 202341-5,333,968-16.72%106.08%12-7.69%129.09%
Mar 31, 202341-18.00%6,404,937-19.88%133.77%13-45.83%11-26.67%
Dec 31, 202250-1.96%7,993,858-26.62%183.02%2414.29%15-6.25%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Victory Extended Market Index5.69K0.01%-

Recent Insider Transactions

DateNameRoleActivityValue
Sep 13, 2023Sebree Terri B PresidentSell$16.44K
Sep 13, 2023Rosenberger Brian VP, Commercial & Business Dev.Sell$8.50K
Sep 13, 2023Fickenscher James E Chief Financial OfficerSell$11.93K
Sep 13, 2023Jones Kenneth T See RemarksSell$3.32K
Sep 13, 2023ANIDO ARMANDO Chairman & Chief Exec. OfficerSell$23.64K

Insider Transactions Trends

DateBuySell
2023 Q4--
2023 Q3-5
2023 Q2-6
2023 Q1-5
2022 Q3-4

ZYNE Ownership FAQ

Who Owns Zynerba Pharmaceuticals?

Zynerba Pharmaceuticals shareholders are primarily institutional investors at 0.03%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Zynerba Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 34.80%, which Zynerba Pharmaceuticals falls below.

Does Blackrock own Zynerba Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Zynerba Pharmaceuticals.

Who is Zynerba Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

B. riley wealth advisors is Zynerba Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Zynerba Pharmaceuticals shares, valued at 0$.

Who is the top mutual fund holder of Zynerba Pharmaceuticals shares?

Victory Extended Market Index is the top mutual fund holder of Zynerba Pharmaceuticals shares, with 0.01% of its total shares outstanding invested in 5.69K Zynerba Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools